Search Results 461-470 of 16234 for pharmacogenetics

  1. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...

  2. A Study to Establish a Registry of Post-COVID Investigations, Education and Symptom Management - Mayo Clinic

    The purpose of this study is to establish a registry that will follow patients that are seen in the PCCOC clinic with Post-COVID symptoms that persist for ...

  3. Hereditary Hemorrhagic Telangiectasia (HHT) Clinic - Overview

    Our HHT Clinic includes specialists in medical genetics; pulmonary medicine and critical care; neurology; neurosurgery; ear, nose and throat (ENT); radiology; ...

  4. Publications - Nneka I. Comfere, M.D. - Mayo Clinic

    Pharmacogenetics in dermatology: a patient-centered update. Int J Dermatol. 2013 Aug; 52(8):1005-12. Epub 2013 Jun 20. View PubMed; Comfere NI, Gonzalez ...

  5. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...

  6. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  7. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.

  8. Discovery and Translation Labs - Mayo Clinic Research

    Researchers in this brain focus area of the Discovery and Translation Labs at Mayo Clinic focus on translational research related to biomarker and drug ...

  9. A Study to Develop a Biobank of Samples from Patients Undergoing Therapy with PCSK9 Inhibitors - Mayo Clinic

    Develop a biobank of samples from patients undergoing therapy with PCSK9 inhibitors (FDA- approved in 2015, therapeutics for hypercholesterolemia) with the goal ...

  10. Clinical trials - Oncology (Medical)

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...